Vesigen Therapeutics picks up $28.5m Series A

Cambridge, Massachusetts-based Vesigen Therapeutics, a biotech company, has raised $28.5 million in Series A funding.

Cambridge, Massachusetts-based Vesigen Therapeutics, a biotech company, has raised $28.5 million in Series A funding. Leaps by Bayer and Morningside Ventures led the round with participation from Linden Lake Ventures and Alexandria Venture Investments.

Source: Press Release